+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Liver Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type and End User- Product Image
Liver Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type and End User- Product Image
Sale

Liver Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type and End User

  • PDF Icon

    Report

  • 181 Pages
  • April 2022
  • Region: Global
  • The Insight Partners
  • ID: 5576267
UP TO OFF until Dec 31st 2024
Description Jump to:
Laboratory Tests Segment to Lead Liver Cancer Diagnostics Market During 2021-2028



According to the latest study on 'Liver Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Type and End User,' the market is expected to grow from US$ 9,323.14 million in 2021 to US$ 15,951.77 million by 2028; it is estimated to grow at a CAGR of 8.0% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments. The growth of the market is primarily attributed to the rising prevalence of liver cancer and increasing R&D investments in the development of novel diagnostic testing. On the other hand, the high cost of technologically advanced liver cancer diagnostic solutions hinders the growth of the market.

The COVID-19 pandemic reduced resources from healthcare services for patients suffering from diseases, such as cancer. COVID-19 causes organ dysfunction, complicating cancer treatment. With COVID-19 outbreak in most countries across the world, modifications to cancer management have been adopted to accommodate the crisis and minimize the exposure of cancer patients to the infection. As per a research article by Chan S.L. et al., published in Liver Cancer Journal 2020, in hepatocellular carcinoma (HCC) patients, COVID-19 exacerbates existing chronic liver disease and complicates cancer management. Cancer patients have a higher risk of infection and worse outcomes, especially those recently undergone cancer treatments.

Based on type, the liver cancer diagnostics market is segmented into laboratory tests, endoscopy, imaging, biopsy, and others. The laboratory tests segment held the largest market share in 2021. However, the imaging segment is anticipated to register a CAGR of 8.6% in the market during the forecast period. The largest share of laboratory tests segment is attributed to the rising prevalence of liver cancer. According to CDC (Centers for Disease Control and Prevention), in the US, about 24,500 men and 10,000 women are diagnosed with liver cancer, and about 18,600 men and 9,000 women die due to the disease each year. The percentage of Americans who get affected by liver cancer has been rising for several decades. Liver cancer is more common in other parts of the world than in the US. Moreover, according to an article published in CCO (Chinese Clinical Oncology), hepatocellular cancer (HCC) is a leading cause of cancer death worldwide. In Europe, HCC accounts for around 47,000 deaths per year. The incidence is comparatively low except in Southern Europe, where the age-standardized incidence rate in men is 9.8 per 100,000 compared with 3.8 in Northern Europe, 4.6 in central and Eastern Europe, and 7.2 in Western Europe. However, in the UK, mortality rates from HCC are expected to rise by 14% between 2006 and 2025, representing the largest increase in any cancer among male. The factors mentioned above increase the incidence of liver cancer, thereby driving the liver cancer diagnostics market.

Abbott; BioMerieux SA; F. HOFFMANN-LA ROCHE LTD.; Illumina, Inc.; Koninklijke Philips N.V.; QIAGEN; Siemens Healthineers AG; THERMO FISHER SCIENTIFIC INC.; GE Healthcare; Perspectum; and Helio, Inc. are a few leading companies operating in the liver cancer diagnostics market.

The report segments the liver cancer diagnostics market as follows:


Based on type, the liver cancer diagnostics market is segmented into laboratory tests, endoscopy, imaging, biopsy, and others. Based on end user, the market is segmented into hospitals and diagnostic laboratories, academic and research institutes, and CRO laboratories. By geography, the liver cancer diagnostics market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global liver cancer diagnostics market
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the global liver cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Liver Cancer Diagnostics Market - By Type
1.3.2 Global Liver Cancer Diagnostics Market - By End User
1.3.3 Global Liver Cancer Diagnostics Market - By Geography
2. Liver Cancer Diagnostics Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Liver Cancer Diagnostics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South And Central America PEST Analysis
4.3 Experts Opinion
5. Liver Cancer Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Liver Cancer
5.1.2 Rising R&D Investments for the Development of Novel Diagnostic Testing
5.2 Market Restraints
5.2.1 High Cost of Technologically Advanced Liver Cancer Diagnostic Solutions
5.3 Market Opportunities
5.3.1 Increasing Demand for Point-of-Care Testing
5.4 Future Trends
5.4.1 Rising Emergence of New Technologies
5.5 Impact Analysis
6. Liver Cancer Diagnostics Market - Global Analysis
6.1 Global Liver Cancer Diagnostics Market Revenue Forecast and Analysis
6.2 Global Liver Cancer Diagnostics Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Liver Cancer Diagnostics Market Analysis - By Type
7.1 Overview
7.2 Liver Cancer Diagnostics Market Revenue Share, by Type (2021 and 2028)
7.3 Laboratory Tests
7.3.1 Overview
7.3.2 Laboratory Tests: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Blood Tests
7.3.2.1.1 Overview
7.3.2.1.2 Blood Tests: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Biomarkers
7.3.2.2.1 Overview
7.3.2.2.2 Biomarkers: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Endoscopy
7.4.1 Overview
7.4.2 Endoscopy: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Imaging
7.5.1 Overview
7.5.2 Imaging: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Biopsy
7.6.1 Overview
7.6.2 Biopsy: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8. Liver Cancer Diagnostics Market Analysis - By End User
8.1 Overview
8.2 Liver Cancer Diagnostics Market Revenue Share, By End User (2021 and 2028)
8.3 Hospitals and Diagnostics Laboratories
8.3.1 Overview
8.3.2 Hospitals and Diagnostics Laboratories: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Academic and Research Institutes
8.4.1 Overview
8.4.2 Academic and Research Institutes: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8.5 CRO Laboratories
8.5.1 Overview
8.5.2 CRO Laboratories: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9. Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 - Geographical Analysis
9.1 North America: Liver Cancer Diagnostics Market
9.1.1 Overview
9.1.2 North America Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.3 North America Liver Cancer Diagnostics Market, by Type- Revenue and Forecast to 2028 (USD Million)
9.1.3.1 North America Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
9.1.4 North America Liver Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
9.1.5 North America: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
9.1.5.1 US: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.5.1.1 Overview
9.1.5.1.2 US: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.5.1.3 US Liver Cancer Diagnostics Market, by Type- Revenue and Forecast to 2028 (USD Million)
9.1.5.1.3.1 US Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
9.1.5.1.4 US Liver Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
9.1.5.2 Canada: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.5.2.1 Overview
9.1.5.2.2 Canada: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.5.2.3 Canada Liver Cancer Diagnostics Market, by Type- Revenue and Forecast to 2028 (USD Million)
9.1.5.2.3.1 Canada Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
9.1.5.2.4 Canada Liver Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
9.1.5.3 Mexico: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.5.3.1 Overview
9.1.5.3.2 Mexico: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.5.3.3 Mexico Liver Cancer Diagnostics Market, by Type- Revenue and Forecast to 2028 (USD Million)
9.1.5.3.3.1 Mexico Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
9.1.5.3.4 Mexico Liver Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
9.2 Europe: Liver Cancer Diagnostics Market
9.2.1 Overview
9.2.2 Europe: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
9.2.3 Europe: Liver Cancer Diagnostics Market, by Type, 2019-2028 (USD Million)
9.2.3.1 Europe: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019-2028 (USD Million)
9.2.4 Europe: Liver Cancer Diagnostics Market, by End User, 2019-2028 (USD Million)
9.2.5 Europe: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
9.2.5.1 Germany: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
9.2.5.1.1 Germany: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
9.2.5.1.2 Germany: Liver Cancer Diagnostics Market, by Type, 2019-2028 (USD Million)
9.2.5.1.2.1 Germany: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019-2028 (USD Million)
9.2.5.1.3 Germany: Liver Cancer Diagnostics Market, by End User, 2019-2028 (USD Million)
9.2.5.2 UK: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
9.2.5.2.1 UK: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
9.2.5.2.2 UK: Liver Cancer Diagnostics Market, by Type, 2019-2028 (USD Million)
9.2.5.2.2.1 UK: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019-2028 (USD Million)
9.2.5.2.3 UK: Liver Cancer Diagnostics Market, by End User, 2019-2028 (USD Million)
9.2.5.3 France: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
9.2.5.3.1 France: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
9.2.5.3.2 France: Liver Cancer Diagnostics Market, by Type, 2019-2028 (USD Million)
9.2.5.3.2.1 France: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019-2028 (USD Million)
9.2.5.3.3 France: Liver Cancer Diagnostics Market, by End User, 2019-2028 (USD Million)
9.2.5.4 Spain: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
9.2.5.4.1 Spain: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
9.2.5.4.2 Spain: Liver Cancer Diagnostics Market, by Type, 2019-2028 (USD Million)
9.2.5.4.2.1 Spain: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019-2028 (USD Million)
9.2.5.4.3 Spain: Liver Cancer Diagnostics Market, by End User, 2019-2028 (USD Million)
9.2.5.5 Italy: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
9.2.5.5.1 Italy: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
9.2.5.5.2 Italy: Liver Cancer Diagnostics Market, by Type, 2019-2028 (USD Million)
9.2.5.5.2.1 Italy: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019-2028 (USD Million)
9.2.5.5.3 Italy: Liver Cancer Diagnostics Market, by End User, 2019-2028 (USD Million)
9.2.5.6 Rest of Europe: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
9.2.5.6.1 Rest of Europe: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
9.2.5.6.2 Rest of Europe: Liver Cancer Diagnostics Market, by Type, 2019-2028 (USD Million)
9.2.5.6.2.1 Rest of Europe: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019-2028 (USD Million)
9.2.5.6.3 Rest of Europe: Liver Cancer Diagnostics Market, by End User, 2019-2028 (USD Million)
9.3 Asia-Pacific: Liver Cancer Diagnostics Market
9.3.1 Overview
9.3.2 Asia-Pacific: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.3.3 Asia-Pacific: Liver Cancer Diagnostics Market, by Type- 2019-2028 (USD Million)
9.3.3.1 Asia-Pacific: Liver Cancer Diagnostics Market, by Laboratory Tests - 2019-2028 (USD Million)
9.3.4 Asia-Pacific: Liver Cancer Diagnostics Market, by End User- 2019-2028 (USD Million)
9.3.5 Asia-Pacific: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
9.3.5.1 China: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.1.1 Overview
9.3.5.1.2 China: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.1.3 China: Liver Cancer Diagnostics Market, by Type- 2019-2028 (USD Million)
9.3.5.1.3.1 China: Liver Cancer Diagnostics Market, by Laboratory Tests - 2019-2028 (USD Million)
9.3.5.1.4 China: Liver Cancer Diagnostics Market, by End User- 2019-2028 (USD Million)
9.3.5.2 Japan: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.2.1 Overview
9.3.5.2.2 Japan: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.2.3 Japan: Liver Cancer Diagnostics Market, by Type- 2019-2028 (USD Million)
9.3.5.2.3.1 Japan: Liver Cancer Diagnostics Market, by Laboratory Tests- 2019-2028 (USD Million)
9.3.5.2.4 Japan: Liver Cancer Diagnostics Market, by End User- 2019-2028 (USD Million)
9.3.5.3 India: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.3.1 Overview
9.3.5.3.2 India: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.3.3 India: Liver Cancer Diagnostics Market, by Type- 2019-2028 (USD Million)
9.3.5.3.3.1 India: Liver Cancer Diagnostics Market, by Laboratory Tests - 2019-2028 (USD Million)
9.3.5.3.4 India: Liver Cancer Diagnostics Market, by End User- 2019-2028 (USD Million)
9.3.5.4 South Korea: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.4.1 Overview
9.3.5.4.2 South Korea: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.4.3 South Korea: Liver Cancer Diagnostics Market, by Type- 2019-2028 (USD Million)
9.3.5.4.3.1 South Korea: Liver Cancer Diagnostics Market, by Laboratory Tests - 2019-2028 (USD Million)
9.3.5.4.4 South Korea: Liver Cancer Diagnostics Market, by End User- 2019-2028 (USD Million)
9.3.5.5 Australia: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.5.1 Overview
9.3.5.5.2 Australia: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.5.3 Australia: Liver Cancer Diagnostics Market, by Type- 2019-2028 (USD Million)
9.3.5.5.3.1 Australia: Liver Cancer Diagnostics Market, by Laboratory Tests- 2019-2028 (USD Million)
9.3.5.5.4 Australia: Liver Cancer Diagnostics Market, by End User- 2019-2028 (USD Million)
9.3.5.6 Rest of Asia-Pacific: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.6.1 Overview
9.3.5.6.2 Rest of Asia-Pacific: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.6.3 Rest of Asia-Pacific: Liver Cancer Diagnostics Market, by Type- 2019-2028 (USD Million)
9.3.5.6.3.1 Rest of Asia-Pacific: Liver Cancer Diagnostics Market, by Laboratory Tests - 2019-2028 (USD Million)
9.3.5.6.4 Rest of Asia-Pacific: Liver Cancer Diagnostics Market, by End User- 2019-2028 (USD Million)
9.4 Middle East & Africa Liver Cancer Diagnostics Market Revenue and Forecasts To
9.4.1 Overview
9.4.2 Middle East & Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.3 Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
9.4.3.1 Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
9.4.4 Middle East & Africa: Liver Cancer Diagnostics Market, by End user - Revenue and Forecast to 2028 (US$ Million)
9.4.5 Middle East & Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
9.4.5.1 UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.1.1 Overview
9.4.5.1.2 UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.1.3 UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
9.4.5.1.3.1 UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
9.4.5.1.4 UAE: Liver Cancer Diagnostics Market, by End user - Revenue and Forecast to 2028 (US$ Million)
9.4.5.2 Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.2.1 Overview
9.4.5.2.2 Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.2.3 Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
9.4.5.2.3.1 Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
9.4.5.2.4 Saudi Arabia: Liver Cancer Diagnostics Market, by End user - Revenue and Forecast to 2028 (US$ Million)
9.4.5.3 South Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.3.1 Overview
9.4.5.3.2 South Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.3.3 South Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
9.4.5.3.3.1 South Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
9.4.5.3.4 South Africa: Liver Cancer Diagnostics Market, by End user - Revenue and Forecast to 2028 (US$ Million)
9.4.5.4 Rest of Middle East and Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.4.1 Overview
9.4.5.4.2 Rest of Middle East and Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.4.3 Rest of Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
9.4.5.4.3.1 Rest of Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
9.4.5.4.4 Rest of Middle East and Africa: Liver Cancer Diagnostics Market, by End user - Revenue and Forecast to 2028 (US$ Million)
9.5 South and Central America Liver Cancer Diagnostics Market Revenue and Forecasts To
9.5.1 Overview
9.5.2 South and Central America: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.5.3 South and Central America Liver Cancer Diagnostics Market, By Type- Revenue and Forecast to 2028 (USD Million)
9.5.3.1 South and Central America Liver Cancer Diagnostics Market, By Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
9.5.4 South and Central America: Liver Cancer Diagnostics Market, by End User, 2019-2028 (USD Million)
9.5.5 South and Central America: Liver Cancer Diagnostics Market Share by Country - 2021 & 2028, (%)
9.5.5.1 Brazil: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)
9.5.5.1.1 Overview
9.5.5.1.2 Brazil: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)
9.5.5.1.3 Brazil Liver Cancer Diagnostics Market, By Type- Revenue and Forecast to 2028 (USD Million)
9.5.5.1.3.1 Brazil Liver Cancer Diagnostics Market, By Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
9.5.5.1.4 Brazil Liver Cancer Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
9.5.5.2 Argentina: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)
9.5.5.2.1 Overview
9.5.5.2.2 Argentina: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)
9.5.5.2.3 Argentina Liver Cancer Diagnostics Market, By Type- Revenue and Forecast to 2028 (USD Million)
9.5.5.2.3.1 Argentina Liver Cancer Diagnostics Market, By Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
9.5.5.2.4 Argentina Liver Cancer Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
9.5.5.3 Rest of South and Central America: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.5.5.3.1 Overview
9.5.5.3.2 Rest of South and Central America: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.5.5.3.3 Rest of South and Central America Liver Cancer Diagnostics Market, By Type- Revenue and Forecast to 2028 (USD Million)
9.5.5.3.3.1 Rest of South and Central America Liver Cancer Diagnostics Market, By Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
9.5.5.3.4 Rest of South and Central America Liver Cancer Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Liver Cancer Diagnostics Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Liver Cancer Diagnostics Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Liver Cancer Diagnostics Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Abbott
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 bioMerieux SA
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 F. HOFFMANN-LA ROCHE LTD.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Illumina, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Koninklijke Philips N.V.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 QIAGEN
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Siemens Healthineers AG
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 THERMO FISHER SCIENTIFIC INC.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 GE Healthcare
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Perspectum
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Helio, Inc
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms
List of Tables
Table 1. North America Liver Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 2. North America Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
Table 3. North America Liver Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 4. US Liver Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 5. US Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
Table 6. US Liver Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 7. Canada Liver Cancer Diagnostics Market, by Type -Revenue and Forecast to 2028 (USD Million)
Table 8. Canada Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Liver Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico Liver Cancer Diagnostics Market, by Type -Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico Liver Cancer Diagnostics Market, by Laboratory Tests -Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico Liver Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 13. Europe Liver Cancer Diagnostics Market, by Type - Revenue and forecast to 20280 (USD Million)
Table 14. Europe Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and forecast to 20280 (USD Million)
Table 15. Europe Liver Cancer Diagnostics Market, by End User - Revenue and forecast to 2028 (USD Million)
Table 16. Germany Liver Cancer Diagnostics Market, by Type - Revenue and forecast to 2028 (USD Million)
Table 17. Germany Liver Cancer Diagnostics Market, by Laboratory Tests- Revenue and forecast to 2028 (USD Million)
Table 18. Germany Liver Cancer Diagnostics Market, by End User - Revenue and forecast to 2028 (USD Million)
Table 19. UK Liver Cancer Diagnostics Market, by Type - Revenue and forecast to 2028 (USD Million)
Table 20. UK Liver Cancer Diagnostics Market, by Laboratory Tests- Revenue and forecast to 2028 (USD Million)
Table 21. UK Liver Cancer Diagnostics Market, by End User - Revenue and forecast to 2028 (USD Million)
Table 22. France Liver Cancer Diagnostics Market, by Type - Revenue and forecast to 2028 (USD Million)
Table 23. France Liver Cancer Diagnostics Market, by Laboratory Tests- Revenue and forecast to 2028 (USD Million)
Table 24. France Liver Cancer Diagnostics Market, by End User - Revenue and forecast to 2028 (USD Million)
Table 25. Spain Liver Cancer Diagnostics Market, by Type - Revenue and forecast to 2028 (USD Million)
Table 26. Spain Liver Cancer Diagnostics Market, by Laboratory Tests- Revenue and forecast to 2028 (USD Million)
Table 27. Spain Liver Cancer Diagnostics Market, by End User - Revenue and forecast to 2028 (USD Million)
Table 28. Italy Liver Cancer Diagnostics Market, by Type - Revenue and forecast to 2028 (USD Million)
Table 29. Italy Liver Cancer Diagnostics Market, by Laboratory Tests- Revenue and forecast to 2028 (USD Million)
Table 30. Italy Liver Cancer Diagnostics Market, by End User - Revenue and forecast to 2028 (USD Million)
Table 31. Rest of Europe: Liver Cancer Diagnostics Market, by Type - Revenue and forecast to 2028 (USD Million)
Table 32. Rest of Europe: Liver Cancer Diagnostics Market, by Laboratory Tests- Revenue and forecast to 2028 (USD Million)
Table 33. Rest of Europe Liver Cancer Diagnostics Market, by End User - Revenue and forecast to 2028 (USD Million)
Table 34. Asia-Pacific Liver Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 35. Asia-Pacific Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
Table 36. Asia-Pacific Liver Cancer Diagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
Table 37. China Liver Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 38. China Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
Table 39. China Liver Cancer Diagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
Table 40. Japan Liver Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 41. Japan Liver Cancer Diagnostics Market, by Laboratory Tests- Revenue and Forecast to 2028 (USD Million)
Table 42. Japan Liver Cancer Diagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
Table 43. India Liver Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 44. India Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
Table 45. India Liver Cancer Diagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
Table 46. South Korea Liver Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 47. South Korea Liver Cancer Diagnostics Market, by Laboratory Tests- Revenue and Forecast to 2028 (USD Million)
Table 48. South Korea Liver Cancer Diagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
Table 49. Australia Liver Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 50. Australia Liver Cancer Diagnostics Market, by Laboratory Tests- Revenue and Forecast to 2028 (USD Million)
Table 51. Australia Liver Cancer Diagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
Table 52. Rest of Asia-Pacific Liver Cancer Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 53. Rest of Asia-Pacific Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
Table 54. Rest of Asia-Pacific Liver Cancer Diagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
Table 55. Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 56. Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
Table 57. Middle East & Africa: Liver Cancer Diagnostics Market, by End user - Revenue and Forecast to 2028 (US$ Million)
Table 58. UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 59. UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
Table 60. UAE: Liver Cancer Diagnostics Market, by End user - Revenue and Forecast to 2028 (US$ Million)
Table 61. Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 62. Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
Table 63. Saudi Arabia: Liver Cancer Diagnostics Market, by End user - Revenue and Forecast to 2028 (US$ Million)
Table 64. South Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 65. South Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
Table 66. South Africa: Liver Cancer Diagnostics Market, by End user - Revenue and Forecast to 2028 (US$ Million)
Table 67. Rest of Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 68. Rest of Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
Table 69. Rest of Middle East and Africa: Liver Cancer Diagnostics Market, by End user - Revenue and Forecast to 2028 (US$ Million)
Table 70. South and Central America Liver Cancer Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
Table 71. South and Central America Liver Cancer Diagnostics Market, By Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
Table 72. South and Central America Liver Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 73. Brazil Liver Cancer Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
Table 74. Brazil Liver Cancer Diagnostics Market, By Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
Table 75. Brazil Liver Cancer Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 76. Argentina Liver Cancer Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
Table 77. Argentina Liver Cancer Diagnostics Market, By Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
Table 78. Argentina Liver Cancer Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 79. Rest of South and Central America Liver Cancer Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
Table 80. Rest of South and Central America Liver Cancer Diagnostics Market, By Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
Table 81. Rest of South and Central America Liver Cancer Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 82. Organic Developments in the Liver Cancer Diagnostics Market
Table 83. Inorganic Developments in the Liver Cancer Diagnostics Market
Table 84. Glossary of Terms
List of Figures
Figure 1. Liver Cancer Diagnostics Market Segmentation
Figure 2. Liver Cancer Diagnostics Market Segmentation, By Region
Figure 3. Global Liver Cancer Diagnostics Market Overview
Figure 4. Laboratory Tests Segment Held Largest Share by Type in Liver Cancer Diagnostics Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Liver Cancer Diagnostics Market, By Geography (US$ Million)
Figure 7. Global Liver Cancer Diagnostics Market- Leading Country Markets (US$ Million)
Figure 8. Global Liver Cancer Diagnostics Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South And Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Impact Analysis of Drivers and Restraint Pertaining to Liver Cancer Diagnostics Market
Figure 16. Global Liver Cancer Diagnostics Market - Revenue Forecast and Analysis - 2021- 2028
Figure 17. Global Liver Cancer Diagnostics Market - By Geography Forecast and Analysis - 2021- 2028.
Figure 18. Market Positioning of Key Players in Global Liver Cancer Diagnostics Market
Figure 19. Liver Cancer Diagnostics Market Revenue Share, by Type (2021 and 2028)
Figure 20. Laboratory Tests: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Blood Tests: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Biomarkers: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Endoscopy: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Imaging: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Biopsy: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Liver Cancer Diagnostics Market Revenue Share, By End User (2021 and 2028)
Figure 28. Hospitals and Diagnostics Laboratories: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Academic and Research Institutes: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. CRO Laboratories: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. North America: Liver Cancer Diagnostics Market, by Key Country - Revenue (2021) (USD Million)
Figure 32. North America Liver Cancer Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 33. North America: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 34. US: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 35. Canada: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 36. Mexico: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 37. Europe: Liver Cancer Diagnostics Market, by Key Country - Revenue (2021) (USD Million)
Figure 38. Europe Liver Cancer Diagnostics Market Revenue and forecast to 2028 (USD Million)
Figure 39. Europe: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 40. Germany: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
Figure 41. UK: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
Figure 42. France: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
Figure 43. Spain: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
Figure 44. Italy: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
Figure 45. Rest of Europe: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
Figure 46. Asia-Pacific: Liver Cancer Diagnostics Market, by Key Country - Revenue (2021) (US$ Million)
Figure 47. Asia-Pacific Liver Cancer Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 48. Asia-Pacific: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 49. China: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ MILLION)
Figure 50. Japan: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 51. India: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 52. South Korea: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 53. Australia: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 54. Rest of Asia-Pacific: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 55. Middle East & Africa Liver Cancer Diagnostics Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 56. Middle East & Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 57. Middle East & Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
Figure 58. UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 59. Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 60. South Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 61. Rest of Middle East and Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 62. South and Central America: Liver Cancer Diagnostics Market, By Key Country - Revenue (2021) (USD Million)
Figure 63. South and Central America: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)
Figure 64. South and Central America: Liver Cancer Diagnostics Market Share by Country - 2021 & 2028, (%)
Figure 65. Brazil: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)
Figure 66. Argentina: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)
Figure 67. Rest of South and Central America: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 68. Impact of COVID-19 Pandemic in North American Country Markets
Figure 69. Impact of COVID-19 Pandemic in European Country Markets
Figure 70. Impact of COVID-19 Pandemic in Asia Pacific Countries
Figure 71. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 72. Impact Of COVID-19 Pandemic in South and Central America Country Markets
Figure 73. Growth Strategies in the Liver Cancer Diagnostics Market (%)

Executive Summary

The Liver cancer diagnostics market size is projected to reach US$ US$ 15,951.77 million by 2028 from US$ 9,323.14 million in 2021; it is estimated to grow at a CAGR of 8.0% during 2021–2028.

The report highlights the key factors driving the market and prominent players with their developments. The growth of the liver cancer diagnostics market is primarily attributed to the rising prevalence of liver cancer and increasing R&D investments in the development of novel diagnostic testing. On the other hand, the high cost of technologically advanced liver cancer diagnostic solutions hinders the growth of the market.

Hepatocellular carcinoma is the most frequent type of liver; it starts in the major type of liver cell (hepatocyte) and is the most common type of primary liver cancer. Hepatocellular carcinoma occurs most often in people with chronic liver diseases, such as cirrhosis caused by hepatitis B or hepatitis C infection. Further, other kinds of liver cancer are significantly less prevalent, such as intrahepatic cholangiocarcinoma and hepatoblastoma. Cancer that begins in another area of the body, such as the colon, lung, or breast, and then spreads to the liver is called metastatic cancer. Moreover, metastatic colon cancer is a kind of cancer that starts in the colon and spreads to the liver. For instance, according to CDC (Centers of Disease Control and Prevention), each year in the US, about 24,500 men and 10,000 women get liver cancer, and about 18,600 men and 9,000 women die from the disease. The percentage of Americans who get liver cancer has been rising for several decades. Liver cancer is more common in other parts of the world than in the US. Moreover, according to an article published in CCO (Chinese Clinical Oncology), hepatocellular cancer (HCC) is a leading cause of cancer death worldwide. In Europe, HCC accounts for around 47,000 deaths per year. The incidence is comparatively low except in Southern Europe, where the age-standardized incidence rate in men is 9.8 per 100,000 compared with 3.8 in Northern Europe, 4.6 in central and Eastern Europe, and 7.2 in Western Europe. However, in the UK, mortality rates from HCC are expected to rise by 14% between 2006 and 2025 representing the largest increase in any male cancer. Furthermore, being overweight or having obesity is a risk factor for liver cancer and non-alcoholic fatty liver disease is a common condition in obese people. People with a subtype of non-alcoholic fatty liver disease, known as non-alcoholic steatohepatitis (NASH), might develop cirrhosis, which can cause liver cancer. According to a research article by Eunsun Kim et al., published in Experimental & Molecular Medicine Journal 2020, the incidence rate associated with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) is increasing, and the global burden of mortality from hepatocellular carcinoma (HCC) is predicted to reach 1 million deaths annually by 2030. In addition, certain inherited metabolic diseases can lead to cirrhosis. Lifestyle and behaviors such as smoking cigarettes and drinking alcohol are the leading cause of cirrhosis in the US, which is linked with an increased risk of liver cancer. Further, Type 2 diabetes has been linked with an increased risk of liver cancer, usually in patients with other risk factors such as heavy alcohol use or chronic viral hepatitis. This risk may also be increased as people with type 2 diabetes tend to be overweight or obese, which, in turn, can cause liver problems. According to IDF Diabetes Atlas Tenth edition 2021, approximately 537 million adults (20-79 years) are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. The factors mentioned above are increasing the chances of liver cancer, thereby driving the liver cancer diagnostics market.

The global liver cancer diagnostics market, based on type, is segmented into laboratory tests, endoscopy, imaging, biopsy, and others. The market for the laboratory tests segment is further segmented into blood tests and biomarkers. The laboratory tests segment held the largest share of the market in 2021. However, the imaging segment is anticipated to register a CAGR of 8.5% in the market during the forecast period. Based on end user, the global liver cancer diagnostics market is segmented into hospitals and diagnostic laboratories, academic and research institutes, and CRO laboratories. The hospitals and diagnostic laboratories segment held the largest share of the market in 2021 as the hospitals provide healthcare facilities through specialized scientific equipment. A team of trained staff is assigned to deal, investigate, and restore the problems associated with modern medical science in the hospital. Various medical research teams are constantly working on introducing innovative technologies related to the diagnostics methods and other activities in the medical field. The patients generally prefer the hospital to take liver cancer treatment due to the availability of advanced treatment options. The hospitals are the point of care for the patients. Moreover, the same segment is anticipated to register a CAGR of 8.5% in the market during the forecast period.

A few of the major primary and secondary sources referred to while preparing the report on the liver cancer diagnostics market are the National Center for Health Statistics; Centers for Disease Control and Prevention (CDC); National Institute of Statistics, Geography, and Informatics; National Health and Medical Research Council; and World Health Organization.

Companies Mentioned

  • Abbott
  • Biomerieux Sa
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Koninklijke Philips N.V
  • Qiagen
  • Siemens Healthineers AG
  • Therm- Fisher Scientific Inc.
  • GE Healthcare
  • Perspectum
  • Helio, Inc.

Table Information

Report AttributeDetails
No. of Pages181
PublishedApril 2022
Forecast Period2021 - 2028
Estimated Market Value ( USD ) in 2021 $ 9323.14 Million
Forecasted Market Value ( USD ) by 2028 $ 15951.77 Million
Compound Annual Growth Rate8.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Liver Cancer Diagnostics Global Market Report 2024 - Product Image

Liver Cancer Diagnostics Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Liver Cancer Diagnostics Market by Test Type, End User - Global Forecast 2025-2030 - Product Image

Liver Cancer Diagnostics Market by Test Type, End User - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Liver Cancer Diagnostics - Global Strategic Business Report - Product Image

Liver Cancer Diagnostics - Global Strategic Business Report

  • Report
  • 88 Pages
  • Global
From
Liver Cancer Diagnostic Test Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Liver Cancer Diagnostic Test Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 84 Pages
  • Global
From
Liver Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Liver Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.